Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere Insulin in Diabetic Subjects with Asthma or COPD
NCT00642616Phase 3Terminated
- Sponsor
- MannKind
- Start
- Mar 2009
- Primary completion
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of Technosphere insulin in type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2DM) (4 arms), sponsored by MannKind. Primary endpoint: Change in Post-bronchodilator FEV1 From Baseline to Week 52. Started Mar 2009; status: terminated.
02
Drugs
Technosphere insulin
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00642616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642616.